From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1r49.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:1r49.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1r49| PDB=1r49 | SCENE= }} | | {{STRUCTURE_1r49| PDB=1r49 | SCENE= }} |
| | | | |
| - | '''Human topoisomerase I (Topo70) double mutant K532R/Y723F'''
| + | ===Human topoisomerase I (Topo70) double mutant K532R/Y723F=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Based on co-crystal structures of human topoisomerase I with bound DNA, Lys(532) makes a minor groove contact with the strongly preferred thymidine residue at the site of covalent attachment (-1 position). Replacement of Lys(532) with either arginine or alanine has essentially no effect on the sequence preference of the enzyme, indicating that this interaction is not required for the preference for a T at the -1 position. Although both the cleavage and religation activities of the K532R mutant enzyme are reduced, cleavage is reduced to a greater extent than religation. The reverse is true for the K532A mutant enzyme with religation so impaired that the nicked intermediate accumulates during plasmid relaxation assays. Consistent with the shift in the cleavage religation equilibrium toward cleavage for the K532A mutant enzyme, expression of the mutant enzyme in Saccharomyces cerevisiae is cytotoxic, and thus this mutant enzyme mimics the effects of the anticancer drug camptothecin. Cleavage assays with the mutant enzymes using an oligonucleotide containing a 5'-bridging phosphorothiolate indicate that Lys(532) functions as a general acid during cleavage to protonate the leaving 5'-oxygen. It is possible that the contact with the -1 base is important during catalysis to provide positional rigidity to the active site. The corresponding residues in the vaccinia virus topoisomerase and the tyrosine recombinases may have similar critical roles in catalysis.
| + | The line below this paragraph, {{ABSTRACT_PUBMED_14594810}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 14594810 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_14594810}} |
| | | | |
| | ==Disease== | | ==Disease== |
| Line 33: |
Line 37: |
| | [[Category: Protein]] | | [[Category: Protein]] |
| | [[Category: Topoisomerase i]] | | [[Category: Topoisomerase i]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 07:03:15 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 17:05:04 2008'' |
Revision as of 14:05, 28 July 2008
Template:STRUCTURE 1r49
Human topoisomerase I (Topo70) double mutant K532R/Y723F
Template:ABSTRACT PUBMED 14594810
Disease
Known disease associated with this structure: DNA topoisomerase I, camptothecin-resistant OMIM:[126420]
About this Structure
1R49 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
The role of lysine 532 in the catalytic mechanism of human topoisomerase I., Interthal H, Quigley PM, Hol WG, Champoux JJ, J Biol Chem. 2004 Jan 23;279(4):2984-92. Epub 2003 Oct 31. PMID:14594810
Page seeded by OCA on Mon Jul 28 17:05:04 2008
